Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages.
Int Immunopharmacol. 2018 Jan;54:354-365. doi: 10.1016/j.intimp.2017.11.032. Epub 2017 Dec 1.
Int Immunopharmacol. 2018.
PMID: 29202299
The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human Hepatocytes.
Febvre-James M, Bruyère A, Le Vée M, Fardel O.
Febvre-James M, et al.
Drug Metab Dispos. 2018 Feb;46(2):131-140. doi: 10.1124/dmd.117.078048. Epub 2017 Nov 21.
Drug Metab Dispos. 2018.
PMID: 29162613
Free article.
Item in Clipboard
Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes.
Febvre-James M, Lecureur V, Fardel O.
Febvre-James M, et al.
Inflamm Res. 2020 Jan;69(1):51-62. doi: 10.1007/s00011-019-01293-1. Epub 2019 Oct 25.
Inflamm Res. 2020.
PMID: 31654094
Item in Clipboard
mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells.
Mayati A, Moreau A, Jouan E, Febvre-James M, Denizot C, Parmentier Y, Fardel O.
Mayati A, et al. Among authors: febvre james m.
Pharmaceutics. 2018 Nov 21;10(4):246. doi: 10.3390/pharmaceutics10040246.
Pharmaceutics. 2018.
PMID: 30469356
Free PMC article.
Item in Clipboard
Cite
Cite